phase i trial - Robuta Search

https://iro.uiowa.edu/esploro/outputs/journalArticle/A-phase-I-trial-of-low-dose/9985141862502771 A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS - University of Iowa Dec 6, 2018 - BACKGROUND. Acute respiratory distress syndrome (ARDS) is a prevalent disease with significant mortality for which no effective pharmacologic therapy exists.... phase i trial carbon monoxide low dose inhaled https://www.austriatoday.com/article/946021982-cyprumed-s-oral-delivery-technology-advances-to-clinical-stage-as-msd-initiates-phase-i-trial Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial |... Austria Today is an online news publication focusing on the Austria phase i trial delivery technology oral advances clinical https://pure.johnshopkins.edu/en/publications/a-phase-i-trial-of-recombinant-human-interleukin-1%CE%B2-oct-43-follow-4/ A phase I trial of recombinant human interleukin-1β (OCT-43) following high-dose chemotherapy and... phase i trial recombinant human interleukin oct https://insight.jci.org/articles/view/194823/table/1 JCI Insight - First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor... phase i trial jci insight brain tumor first child https://www.patlynk.com/fr/trial/NCT00001398 A Phase I/II Trial of Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) in Patients... This trial, sponsored by Amgen, Inc., which produces the recombinant methionyl human stem cell factor (r-metHuSCF), also involves two other institutions. The pr stem cell factor phase i trial recombinant methionyl https://research.uniupo.it/it/publications/a-pilot-randomized-placebo-controlled-double-blind-phase-i-trial-/ A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator... phase i trial placebo controlled double blind of the pilot https://www.todayinscience.com/article/946659132-viromissile-completes-first-dose-cohort-of-phase-i-trial-of-intravenously-dosed-idov-2-safety-review-committee-clears-advancement-to-next-cohort ViroMissile Completes First Dose Cohort of Phase I Trial of Intravenously-Dosed IDOV-2; Safety... phase i trial completes first dose cohort https://scholars.aku.edu/en/publications/phase-i-trial-of-a-recombinant-vaccinia-virus-encoding-carcinoemb/ Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic... phase i trial vaccinia virus carcinoembryonic antigen recombinant encoding https://nordiclifescience.org/alligator-completes-phase-trial/ Alligator completes Phase I trial - NLS Apr 5, 2017 - Biotech company Alligator Biosciences has finished its first Phase I clinical trial with the immuno-oncology antibody ADC-1013. CDMO Cobra Biologics has... phase i trial alligator completes nls https://www.patlynk.com/trial/NCT00000946 A Phase I Trial to Evaluate the HIV-1 SF-2 Recombinant p24 Subunit Vaccine [Chiron Vaccines]... There are currently several Phase I and II clinical trials being performed within AVEG to evaluate different HIV-1 vaccine candidates. The HIV-1 vaccination app phase i trial the hiv subunit vaccine evaluate recombinant https://scholarlyworks.lvhn.org/administration-leadership/7835/ "Phase I trial using the proteasome inhibitor bortezomib and concurrent" by Gregory J Kubicek, Rita... PURPOSE: Advanced head-and-neck cancer (HNC) remains a difficult disease to cure. Proteasome inhibitors such as bortezomib have the potential to improve... phase i trial proteasome inhibitor using bortezomib concurrent https://www.biocentury.com/article/61593/lexirin-lxr-will-start-this-month-a-phase-i-trial-of-lexirin-in-aids-patients-with-severe-diarrhea BioCentury - Lexirin: LXR will start this month a Phase I trial of Lexirin in AIDS patients with... LXR Biotechnology Inc. (LXR), Richmond, Calif. Product: Lexirin, small molecule apoptosis modulator Indication: Severe diarrhea in AIDS Status: LXR will st... phase i trial this month of in aids patients lxr https://www.businesswire.com/news/home/20250929583011/en/Virometix-Announces-Completion-of-Enrollment-in-Phase-I-Trial-of-V-212-a-Fully-Synthetic-Serotype-Independent-Vaccine-Candidate-Against-Streptococcus-Pneumoniae Virometix Announces Completion of Enrollment in Phase I Trial of V-212 — a Fully Synthetic,... Virometix AG, a Swiss clinical-stage biotechnology company pioneering fully synthetic vaccines, today announced that it has successfully completed enrollment... phase i trial announces completion enrollment fully https://usiena-air.unisi.it/handle/11365/981190 Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer... phase i trial thymidylate synthase advanced cancer poly epitope